跳至主要内容
临床试验/EUCTR2012-002889-12-DK
EUCTR2012-002889-12-DK进行中(未招募)1 期

The effect of intraoperative low dose adrenaline on bleeding in total hip arthroplasty - a randomized placebo-controlled trial

Pär I Johansson0 个研究点开始时间: 2012年7月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age > 18 years.
  • - Scheduled for primary unilateral hip arthroplasty
  • - Able to give consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • - Allergy towards adrenaline
  • - Current treatment with: ADP receptor inhibitors or Vitamin K antagonists (within 5 days), Factor Xa inhibitors or Thrombin inhibitors (within 1 day), heparin (excluding low molecular weight heparin for peripoerative thromboprophylaxsis).
  • - Current treatment with tricyclic antidepressants
  • - Use of MAO inhibitors (within previous 14 days) or COMT inhibitors (within 2 days).
  • - Acute coranary syndrome / myocardial infarction within the previous 6 months.
  • - not willing to accept blood transfusion
  • - Participation in other clinical trial within previous 30 days
  • - Women with without menopause for at least 12 months.
  • - Claucoma
  • - Pheocromacytoma
  • - Low serum K+ (< 3.0 mmol/L)
  • - Thyrotoxicosis
  • - Digoxin intoxication
  • - Alcohol og drug abuse (investigators judgement)

研究者

发起方
Pär I Johansson

相似试验